Avaleht › Atoopiline dermatiit (ekseem) › Indiana
Atoopiline dermatiit (ekseem) kliinilised uuringud osariigis Indiana
9 uuringut haiguse Atoopiline dermatiit (ekseem) jaoks otsivad osalejaid osariigis Indiana.
Linnad osariigis Indiana
Ametlik uuringutekst (inglise keeles)
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
- Clinical Site 106, Plainfield
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–65 · Kõik sood · Uuendatud 29. sept 2026 · NCT07453602Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Clarksville
- Enveda Investigative Site, New Albany
- Enveda Investigative Site, West Lafayette
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 25. sept 2026 · NCT07298395A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
VärbamineFaas 3
Vanused 2–11 · Kõik sood · Uuendatud 25. sept 2026 · NCT06807281A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- DS Research of Southern Indiana,LLC, Clarksville
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 28. aug 2026 · NCT07599813A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Indianapolis
- Enveda Investigative Site, Plainfield
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 6. aug 2026 · NCT07643766A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Dawes Fretzin /ID# 265097, Indianapolis
VärbamineFaas 3
Vanused 2–11 · Kõik sood · Uuendatud 6. aug 2026 · NCT06461897A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Options Research Group /ID# 264564, West Lafayette
VärbamineFaas 3
Vanused 18–63 · Kõik sood · Uuendatud 6. juuli 2026 · NCT06389136A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
- Southern Indiana Clinical Trials, New Albany
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. mai 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 8142, Indianapolis
- Galderma Investigational Site 7083, West Lafayette
VärbamineVaatlusuuring
Vanused 12 ja vanemad · Kõik sood · Uuendatud 13. märts 2026 · NCT06988605Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.